- Exchange: OTC BB
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Talon Therapeutics Inc
+ Add to WatchlistTLON:US
0.4150 USD 0.0400 8.79%As of 20:10:00 ET on 05/17/2013.
Snapshot for Talon Therapeutics Inc (TLON)
| Open: | 0.4540 | Day's Range: | 0.4150 - 0.4540 | Volume: | 10,350 |
|---|---|---|---|---|---|
| Previous Close: | 0.4550 | 52wk Range: | 0.4000 - 1.8300 | 1-Yr Rtn: | -44.30% |
Key Statistics for TLON
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -5.4300 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 9.13 |
| Shares Outstanding (M) | 22.01 |
| 30 Day Average Volume | 37,631 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/13/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for TLON
Company Profile & Key Executives for TLON
Talon Therapeutics Inc. is a biopharmaceutical company dedicated to developing and commercializing cancer therapies. The Company's lead product candidate potentially treats acute lymphoblastic leukemia and lymphomas.
| Steven R DeitcherPresident/CEO | Craig W CarlsonSenior VP/CFO |
| Samir M GharibDirector:Finance/Controller |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
TLON News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page